Media Publications - Critical Path Institute

June 13, 2023

C-Path’s PSTC Receives Positive FDA Response for Drug-Induced Pancreatic Injury Biomarkers

Safety biomarkers aim to provide an additional tool for detecting acute drug-induced pancreatic injury (DIPI) in phase 1 clinical

June 12, 2023

Although fosfomycin is currently approved for treating urinary tract infections, it is increasingly being used as salvage...

Critical Path Institute’s Dr. Diane Stephenson joined host Alaina Webster to discuss the importance of data sharing to improve..

June 8, 2023

A Major Milestone for Pediatric Real-World Data Project TUCSON, Ariz., June 8, 2023 — Critical Path Institute‘s (C-Path) I

June 7, 2023

TUCSON, Ariz., June 7, 2023 — Critical Path Institute (C-Path) announced today that Newcastle University UK’s John Walton Musc

June 7, 2023-June 8, 2023

Panel within a virtual workshop presented by The Duke-Margolis Center for Health Policy, under a cooperative agreement with the U.

June 7, 2023

TUCSON, Ariz. and AMSTERDAM, June 7, 2023 — Critical Path Institute (C-Path), a leading global nonprofit committed to expediting

May 31, 2023

TUCSON, Ariz., May 31, 2023 — Critical Path Institute (C-Path) announced today that the CACNA1A Foundation, a parent-led nonprof

May 31, 2023

C-Path’s Transplant Therapeutics Consortium is pleased to announce the recent publication in the American Journal of Transplan

C-Path is proud to welcome Red Nucleus Clinical as the newest member of its Electronic Clinical Outcome Assessment (eCOA) Consor